Jeffrey S. Borer, M.D., is Professor of Medicine, Cell Biology, Radiology and Surgery at the State University of New York Downstate Medical Center. He is Chairman, Department of Medicine and Chief, Division of Cardiovascular Medicine, and Director of two research institutes at Downstate.
Dr. Borer received his BA from Harvard, his M.D. from Cornell, trained at the Massachusetts General Hospital, spent 7 years in the Cardiology Branch of the NHLBI and a year at Guy’s Hospital in London as a Senior Fullbright Hays Scholar and Glorney-Raisbeck Fellow in the Medical Sciences, where he completed the first clinical demonstration of nitroglycerin’s utility in acute myocardial infarction following several years of preclinical enabling studies that he performed at NIH.
Upon returning to the NIH, he developed stress radionuclide cineangiography, enabling for the first time the non-invasive assessment of cardiac function with exercise. He returned to Cornell for 30 years as Gladys and Roland Harriman Professor of Cardiovascular Medicine and Chief of the Division of Cardiovascular Pathophysiology. At Cornell and now at SUNY Downstate, in addition to teaching and clinical service, his research primarily has involved developing prognosticators for regurgitant valve diseases, exploring the cellular/molecular myocardial biology of valve diseases, and assessing the effects of heart rate modulation on clinical outcomes, with trials in coronary artery disease and heart failure.
He has been an Advisor to the USFDA for 35 years, chairing the CardioRenal Drugs Advisory Committee for 3 terms, and the Circulatory Devices Advisory Panel for one term, was a life sciences Advisor to NASA for 24 years, has served as officer or board member of several national professional societies (current President of the Heart Valve Society of America), has published almost 450 scientific papers and 5 books, is editor-in-chief of the journal, Cardiology, and has received several awards and other recognitions for his work.